TRIASTEK南京三迭纪医药科技有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis 2022-11-21 21:00
Triastek announces research collaboration with Lilly to explore the application of 3D printing technology in oral delivery of drugs 2022-07-14 09:00
Triastek and Siemens announce strategic collaboration to accelerate digital transformation of the pharmaceutical industry 2022-03-17 21:24
Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE 2021-06-25 00:26
Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE 2021-06-24 20:43
1